Recruiting Lung Cancer Studies in New Orleans
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
To Determine if SAbR improves survival over SR in High Risk Operable Stage I NSCLC...
A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the Lungs
The Sponsor is developing KB707, a replication-defective, non-integrating herpes simplex virus type 1 (HSV-1)-derived vector that is designed to stimulate an anti-tumor immune response through the pro...
About Lung Cancer Clinical Trials in New Orleans
Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.
There are currently 2 lung cancer clinical trials recruiting participants in New Orleans, LA. These studies are seeking a combined 472 participants. Research is being sponsored by University of Texas Southwestern Medical Center, Krystal Biotech, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lung Cancer Clinical Trials in New Orleans — FAQ
Are there lung cancer clinical trials in New Orleans?
Yes, there are 2 lung cancer clinical trials currently recruiting in New Orleans, LA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New Orleans?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New Orleans research site will contact you about next steps.
Are clinical trials in New Orleans free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New Orleans studies also compensate for your time and travel.
What lung cancer treatments are being tested?
The 2 active trials in New Orleans are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.
Data updated March 2, 2026 from ClinicalTrials.gov